Invenomic Capital Management LP Iridex Corp Transaction History

Invenomic Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.29 - $7.98 $983,724 - $1.25 Million	-156,395 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.67 - $9.2 $17,675 - $24,379	-2,650 Reduced 1.67%	156,395 $1.1 Million
Q1 2021 May 13, 2021	SELL	$2.18 - $7.71 $745,062 - $2.64 Million	-341,772 Reduced 68.24%	159,045 $1.07 Million
Q4 2020 Feb 17, 2021	BUY	$1.62 - $2.91 $96,239 - $172,874	59,407 Added 13.46%	500,817 $1.26 Million
Q3 2020 Nov 13, 2020	BUY	$1.78 - $2.51 $55,404 - $78,126	31,126 Added 7.59%	441,410 $866,000
Q1 2020 May 13, 2020	BUY	$1.4 - $3.64 $645 - $1,678	461 Added 0.11%	410,284 $660,000
Q4 2019 Feb 14, 2020	BUY	$1.77 - $2.57 $725,386 - $1.05 Million	409,823 New	409,823 $918,000

3.3M

500

33.5K

Ticker IRIX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 15,985,600
Market Cap $28.3M
Description
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Invenomic Capital Management LP with notifications on news.